CBI probing Surya Pharmaceuticals in Rs 6.2 billion bank fraud case

Indian police have launched an investigation into a Delhi-based pharmaceutical company for allegedly defrauding state-run Punjab & Sind Bank and four other banks of 6.21 billion rupees ($94.57 million), police said.

"Investigation is continuing," Central Bureau of Investigation (CBI), the federal police, said in a statement on Tuesday. The CBI said the searches were conducted at seven locations and recovered some documents. The police acted following a complaint from the Punjab & Sind Bank against Surya Pharmaceuticals.

This article is no longer available in our repository.

There could be multiple reasons for this.